Selenium adjuvant therapy in septic patients selected according to Carrico index

Clinical Biochemistry

Volumn 47, Issue 15, 2014, Pages 44-50

  Kočan, Ladislav ^a   Vašková, Janka ^b   Vaško, Ladislav ^b   Šimonová, Jana ^a   Šimon, Róbert ^a   Firment, Jozef ^a  

^a L PASTEUR UNIVERSITY HOSPITAL   (Slovakia)

^b P J AFÁRIK UNIVERSITY   (Slovakia)

Author keywords

Oxidative stress; Oxygenation index; Renal functions; Selenium; Sepsis

Indexed keywords

ALANYLGLUTAMINE; ANTIOXIDANT; ASCORBIC ACID; COBALAMIN; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; PLACEBO; PYRIDOXINE; SODIUM SELENITE; SUPEROXIDE DISMUTASE; THIAMINE; TOCOPHEROL; SELENIUM;

ACUTE LUNG INJURY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CARRICO INDEX; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; ENZYME ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; RESPIRATORY TRACT PARAMETERS; SEPSIS; TREATMENT OUTCOME; ADJUVANT CHEMOTHERAPY; DRUG EFFECTS; METABOLISM; MIDDLE AGED; OXIDATIVE STRESS; PATHOLOGY;

ADULT; AGED; ANTIOXIDANTS; CHEMOTHERAPY, ADJUVANT; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PROSPECTIVE STUDIES; SELENIUM; SEPSIS;

EID: 84910090331     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2014.07.004     Document Type: Article

References (29)

1. Vincent J.L. The international sepsis forum's frontiers in sepsis: high cardiac output should be maintained in severe sepsis. Crit Care 2003, 7:276-278.
2. Dellinger R.P., Levy M.M., Carlet J.M., Bion J., Parker M.M., Jaeschker R., et al. Surviving sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36:296-327.
3. Varga M. Bronchial hyperreactivity 2011, 1:1-31. I-med, [http://www.i-med.sk/moodle/login/index.php.].
4. Hawker F.H., Ward H.E., Steward P.M., Wynne L.A., Snitch P.J. Selenium deficiency augments pulmonary toxic effects of oxygen exposure in the rat. Eur Respir J 1993, 6:1317-1323.
5. Angstwurm M.W., Engelmann L., Zimmermann T., Lehmann C., Spes C.H., Abel P., et al. Selenium in Intensive Care (SIC): results of a prospective, randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit Care Med 2007, 35:118-126.
6. Hardy G., Hardy I. Selenium: the Se-XY nutraceutical. Nutrition 2004, 20:590-593.
7. Rayman M.P. The importance of selenium to human health. Lancet 2000, 356:233-241.
8. Chu F.F., Doroshow J.S., Esworthy R.S. Expression, characterization and tissue distribution of a new cellular Se-dependent glutathione peroxidase, GSHPX-GI. J Biol Chem 1993, 268:2571-2576.
9. Forceville X., Laviolle B., Annane D., Vitoux D., Bleichner G., Korach J.M., et al. Effects of high doses of selenium, as sodium selenite, in septic shock: a placebo-controlled, randomized, double-blind, phase II study. Crit Care 2007, 11:R73.
10. Heyland D. Selenium supplementation in critically ill patients: can too much of a good thing be a bad thing?. Crit Care 2007, 11:153.
11. Kuklinski B., Zimmermann T., Schweder R. Decreasing mortality in acute pancreatitis with sodium selenite. Clinical results of 4years antioxidant therapy. Med Klin (Munich) 1995, 90:36-41.
12. Andrews P.J., Avenell A., Noble D.W., Campbell M.K., Croal B.L., Sipmson W.G., et al. Scottish Intensive care Glutamine or seleNium Evaluative Trial Trials Group. Randomised trial of glutamine, selenium, or both, to supplement parenteral nutrition for critically ill patients. BMJ 2011, 342:d1542. 10.1136/bmj.d1542.
13. Valenta J., Brodska H., Drabek T., Hendl J., Kazda A. High-dose selenium substitution in sepsis: a prospective randomized clinical trial. Intensive Care Med 2011, 37:808-815.
14. Finley J.W., Duffield A., Ha P., Vanderpool R.A., Thomson C.D. Selenium supplementation affects the retention of stable isotopes of selenium in human subjects consuming diets low in selenium. Br J Nutr 1999, 82:357-360.
15. Levy M.M., Fink M.P., Marshall J.C., Abraham E., Angus D., Cook D., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2003, 29:530-538.
16. Vašková J., Kočan L., Vaško L., Firment J. Restoration of antioxidant enzymes in therapeutic use of selenium in septic patients. Wien Klin Wochenschr 2013, 125:316-325.
17. Briz O., Romero M.R., Martinez-Becerra P., Macias R.I., Perez M.J., Jimenez F., et al. OATP8/1B3-mediated cotransport of bile acids and glutathione: an export pathway for organic anions from hepatocytes?. J Biol Chem 2006, 281:30326-30335.
18. Hwang T.L. Potential use of albumin administration in severe sepsis. J Chin Med Assoc 2009, 5:225-226.
19. Montejo J.C., Zarazaga A., López-Martínez J., Urrútia G., Roqué M., Blesa A.L., et al. Immunonutrition in the intensive care unit. A systematic review and concensus statement. Clin Nutr 2003, 22:221-223.
20. Pontes-Arruda A., Demichele S., Seth A., Singer P. The use of an inflammation-modulating diet in patients with acute lung injury or acute respiratory distress syndrome: a meta-analysis of outcome data. J Parenter Enter Nutr 2008, 32:596-605.
21. Wastney M.E., Combs G.F., Canfield W.K., Taylor P.R., Patterson K.Y., Hill A.D., et al. A human model of selenium that integrates metabolism from selenite and selenomethionine. J Nutr 2011, 141:708-717.
22. Avissar N., Omt D., Yagil Y., Horowitz S., Watkins R.H., Kerl E.A., et al. Human kidney proximal tubules are the main source of plasma glutathione peroxidase. Am J Physiol 1994, 266:C367-C375.
23. El-far M.A., Bakr M.A., Farahat S.E., Abd El-Fattah E.A. Glutathione peroxidase activity in patients with renal disorders. Clin Exp Nephrol 2005, 9:127-131.
24. Ritter C., Andrades M., Frota Júnior M.L., Bonatto F., Pinho R.A., Polydoro M., et al. Oxidative parameters and mortality in sepsis induced by cecal ligation and perforation. Intensive Care Med 2003, 29:1782-1789.
25. Kharb S., Singh V., Ghalaut P.S., Sharma A., Singh G.P. Role of oxygen free radicals in shock. J Assoc Physicians India 2000, 48:956-957.
26. Bela P., Bahl R., Sane A.S., et al. Oxidative stress status: possible guideline for clinical management of critically ill patients. Panminerva Med 2001, 43:27-31.
27. Carroll M.C., Giroaurd J.B., Ulloa J.L., Subramaniam J.R., Wong P.C., Valentine J.S., et al. Mechanisms for activating Cu- and Zn-containing superoxide dismutase in the absence of CCS Cu chaperone. Proc Natl Acad Sci U S A 2004, 101:5964-5969.
28. Rech M., To L., Tovbin A., Smoot T., Mlynarek M. Heavy metal in the intensive care unit: a review of current literature on trace element supplementation in critically ill patients. Nutr Clin Pract 2014, 29:78-89.
29. Záhorec R., Firment J., Straková J., Mikula J., Malik P., Novák I., et al. Epidemiology of severe sepsis in intensive care units in the Slovak Republic. Infection 2005, 33:122-128.